Your browser doesn't support javascript.
loading
Modulation of midbrain neurocircuitry by intranasal insulin.
Edwin Thanarajah, Sharmili; Iglesias, Sandra; Kuzmanovic, Bojana; Rigoux, Lionel; Stephan, Klaas E; Brüning, Jens C; Tittgemeyer, Marc.
Affiliation
  • Edwin Thanarajah S; Max-Planck-Institute for Metabolism Research, Cologne, Germany; Department of Neurology, University Hospital of Cologne, Cologne, Germany.
  • Iglesias S; Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland.
  • Kuzmanovic B; Max-Planck-Institute for Metabolism Research, Cologne, Germany.
  • Rigoux L; Max-Planck-Institute for Metabolism Research, Cologne, Germany.
  • Stephan KE; Max-Planck-Institute for Metabolism Research, Cologne, Germany; Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland.
  • Brüning JC; Max-Planck-Institute for Metabolism Research, Cologne, Germany; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital of Cologne, Cologne, Germany.
  • Tittgemeyer M; Max-Planck-Institute for Metabolism Research, Cologne, Germany; Modern Diet and Physiology Center, USA; Cologne Cluster of Excellence in Cellular Stress and Aging-Associated Disease (CECAD), Cologne, Germany. Electronic address: tittgemeyer@sf.mpg.de.
Neuroimage ; 194: 120-127, 2019 07 01.
Article in En | MEDLINE | ID: mdl-30914385
Insulin modulates dopamine neuron activity in midbrain and affects processes underlying food intake behaviour, including impulsivity and reward processing. Here, we used intranasal administration and task-free functional MRI in humans to assess time- and dose-dependent effects of insulin on functional connectivity of the dopaminergic midbrain - and how these effects varied depending on systemic insulin sensitivity as measured by HOMA-IR. Specifically, we used a repeated-measures design with factors dose (placebo, 40 IU, 100 IU, 160 IU), time (7 time points during a 90 min post-intervention interval), and group (low vs. high HOMA-IR). A factorial analysis identified a three-way interaction (with whole-brain significance) with regard to functional connectivity between midbrain and the ventromedial prefrontal cortex. This interaction demonstrates that systemic insulin sensitivity modulates the temporal course and dose-dependent effects of intranasal insulin on midbrain functional connectivity. It suggests that altered insulin sensitivity may impact on dopaminergic projections of the midbrain and might underlie the dysregulation of reward-related and motivational behaviour in obesity and diabetes. Perhaps most importantly, the time courses of midbrain functional connectivity we present may provide useful guidance for the design of future human studies that utilize intranasal insulin administration.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Mesencephalon / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Neuroimage Journal subject: DIAGNOSTICO POR IMAGEM Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Mesencephalon / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Neuroimage Journal subject: DIAGNOSTICO POR IMAGEM Year: 2019 Type: Article Affiliation country: Germany